These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 26376419)

  • 21. [Controversies and dilemmas on the use of beta-blockers in treatment of associated cardiovascular disease in patients with chronic obstructive pulmonary disease].
    Pescaru C; Tudorache V; Oancea C
    Pneumologia; 2010; 59(1):27-30. PubMed ID: 20432790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence of potential bias in a comparison of β blockers and calcium channel blockers in patients with chronic obstructive pulmonary disease and acute coronary syndrome: results of a multinational study.
    Dong YH; Alcusky M; Maio V; Liu J; Liu M; Wu LC; Chang CH; Lai MS; Gagne JJ
    BMJ Open; 2017 Mar; 7(3):e012997. PubMed ID: 28363921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of cardioselective beta-blockers on mortality in patients with chronic obstructive pulmonary disease and atherosclerosis.
    van Gestel YR; Hoeks SE; Sin DD; Welten GM; Schouten O; Witteveen HJ; Simsek C; Stam H; Mertens FW; Bax JJ; van Domburg RT; Poldermans D
    Am J Respir Crit Care Med; 2008 Oct; 178(7):695-700. PubMed ID: 18565952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease.
    Rutten FH; Zuithoff NP; Hak E; Grobbee DE; Hoes AW
    Arch Intern Med; 2010 May; 170(10):880-7. PubMed ID: 20498416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can beta-blockers be used for people with COPD?
    Drug Ther Bull; 2011 Jan; 49(1):2-5. PubMed ID: 21220252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of beta-blockers in patients with COPD: current perspective.
    Malerba M; Montuschi P; Radaeli A; Pirisi M
    Drug Discov Today; 2015 Jan; 20(1):129-35. PubMed ID: 25238736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD.
    Huang YL; Lai CC; Wang YH; Wang CY; Wang JY; Wang HC; Yu CJ; Chen L
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2987-2996. PubMed ID: 29066880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD).
    Duffy S; Marron R; Voelker H; Albert R; Connett J; Bailey W; Casaburi R; Cooper JA; Curtis JL; Dransfield M; Han MK; Make B; Marchetti N; Martinez F; Lazarus S; Niewoehner D; Scanlon PD; Sciurba F; Scharf S; Reed RM; Washko G; Woodruff P; McEvoy C; Aaron S; Sin D; Criner GJ;
    Respir Res; 2017 Jun; 18(1):124. PubMed ID: 28629419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease.
    Kubota Y; Asai K; Furuse E; Nakamura S; Murai K; Tsukada YT; Shimizu W
    Int J Chron Obstruct Pulmon Dis; 2015; 10():515-23. PubMed ID: 25784798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-blockers are under-prescribed in patients with chronic obstructive pulmonary disease and co-morbid cardiac disease.
    Neef PA; McDonald CF; Burrell LM; Irving LB; Johnson DF; Steinfort DP
    Intern Med J; 2016 Nov; 46(11):1336-1340. PubMed ID: 27813357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. β-blockers and their mortality benefits: underprescribed in heart failure and chronic obstructive pulmonary disease.
    Rutten FH
    Future Cardiol; 2011 Jan; 7(1):43-53. PubMed ID: 21174509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The place of β-adrenoblockers in the treatment of cardiovascular disease in patients with chronic obstructive pulmonary disease].
    Statsenko ME; Derevianchenko MV
    Kardiologiia; 2012; 52(12):57-63. PubMed ID: 23237442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Usage of beta-adrenolytic agents in patients with chronic pulmonary obstructive disease].
    Bułdak Ł; Duława A; Krysiak R; Okopień B
    Pol Merkur Lekarski; 2008 Feb; 24(140):121-4. PubMed ID: 18637263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: an efficacy and safety analysis of SHIFT study.
    Tavazzi L; Swedberg K; Komajda M; Böhm M; Borer JS; Lainscak M; Robertson M; Ford I;
    Int J Cardiol; 2013 Dec; 170(2):182-8. PubMed ID: 24225201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of β-blocker use with survival and pulmonary function in patients with chronic obstructive pulmonary and cardiovascular disease: a systematic review and meta-analysis.
    Yang YL; Xiang ZJ; Yang JH; Wang WJ; Xu ZC; Xiang RL
    Eur Heart J; 2020 Dec; 41(46):4415-4422. PubMed ID: 33211823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Beta-blockers usage in cardio-vascular diseases co-existing with COPD].
    Walczak D; Kowal A; Jankowska R
    Pol Merkur Lekarski; 2012 Dec; 33(198):338-41. PubMed ID: 23437704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Beta-blockers in COPD: time for reappraisal.
    Lipworth B; Wedzicha J; Devereux G; Vestbo J; Dransfield MT
    Eur Respir J; 2016 Sep; 48(3):880-8. PubMed ID: 27390282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Challenges in the Management of Patients with Chronic Obstructive Pulmonary Disease and Heart Failure With Reduced Ejection Fraction.
    Jaiswal A; Chichra A; Nguyen VQ; Gadiraju TV; Le Jemtel TH
    Curr Heart Fail Rep; 2016 Feb; 13(1):30-6. PubMed ID: 26780914
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beta-blockers in chronic obstructive pulmonary disease: the good, the bad and the ugly.
    Leitao Filho FS; Choi L; Sin DD
    Curr Opin Pulm Med; 2021 Mar; 27(2):125-131. PubMed ID: 33332878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardioselective Versus Nonselective β-Blockers After Myocardial Infarction in Adults With Chronic Obstructive Pulmonary Disease.
    Chung CM; Lin MS; Chang ST; Wang PC; Yang TY; Lin YS
    Mayo Clin Proc; 2022 Mar; 97(3):531-546. PubMed ID: 35135688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.